Genotoxicity and cytotoxicity of zinc oxide and titanium dioxide in HEp-2 cells

Nanomedicine

Volumn 5, Issue 8, 2010, Pages 1193-1203

  Osman, Ilham F ^a   Baumgartner, Adolf ^a   Cemeli, Eduardo ^a   Fletcher, Jonathan N ^a   Anderson, Diana ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

cytotoxicity; genotoxicity; HEp 2 cells; nanoparticles; titanium dioxide; zinc oxide

Indexed keywords

NANOPARTICLE; NEUTRAL RED; TITANIUM DIOXIDE; TYROSINE; ZINC OXIDE;

ARTICLE; CELL MEMBRANE; CELL VIABILITY; COMET ASSAY; CONTROLLED STUDY; CYTOGENETICS; CYTOKINESIS; CYTOTOXICITY; DNA DAMAGE; DOSE RESPONSE; GENOTOXICITY; HEP 2 CELL; HUMAN; HUMAN CELL; MICRONUCLEUS TEST; MITOCHONDRION; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; UPREGULATION;

CELL SURVIVAL; COMET ASSAY; DNA DAMAGE; DNA, NEOPLASM; FEMALE; HELA CELLS; HUMANS; LYSOSOMES; MITOCHONDRIA; NANOPARTICLES; PHOSPHOTYROSINE; PHOTOSENSITIZING AGENTS; TITANIUM; UTERINE CERVICAL NEOPLASMS; ZINC OXIDE;

EID: 78149303282     PISSN: 17435889     EISSN: None     Source Type: Journal    
DOI: 10.2217/nnm.10.52     Document Type: Article

References (66)

1. Kubik T, Bogunia-Kubik K, Sugisaka M: Nanotechnology on duty in medical applications. Curr. Pharm. Biotechnol. 6(1), 17-33 (2005).
2. Lavan Da, Mcguire T, Langer R: Small-scale systems for in vivo drug delivery. Nat. Biotechnol. 21(10), 1184-1191 (2003).
3. Leary SP, Liu CY, Apuzzo ML: Toward the emergence of nanoneurosurgery: Part III - nanomedicine: targeted nanotherapy, nanosurgery, and progress toward the realization of nanoneurosurgery. Neurosurgery 58(6), 1009-1026; discussion 1009-1026 (2006).
4. Schuler M, Trentin D, Textor M, Tosatti SG: Biomedical interfaces: titanium surface technology for implants and cell carriers. Nanomedicine 1(4), 449-463 (2006).
5. Rozhkova EA, Ulasov I, Lai B, Dimitrijevic NM, Lesniak MS, Rajh T: A high-performance nanobio photocatalyst for targeted brain cancer therapy. Nano. Lett. 9(9), 3337-3342 (2009).
6. Sun W, Xie C, Wang H, Hu Y: Specific role of polysorbate 80 coating on the targeting of nanoparticles to the brain. Biomaterials 25(15), 3065-3071 (2004).
7. Teeguarden JG, Hinderliter PM, Orr G, Thrall BD, Pounds JG: Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments. Toxicol. Sci. 95(2), 300-312 (2007).
8. Oberdorster G, Oberdorster E, Oberdorster J: Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 113(7), 823-839 (2005).
9. Foley S, Crowley C, Smaihi M et al.: Cellular localisation of a water-soluble fullerene derivative. Biochem. Biophys. Res. Commun. 294(1), 116-119 (2002).
10. Colvin VL: The potential environmental impact of engineered nanomaterials. Nat. Biotechnol. 21(10), 1166-1170 (2003).
11. Goldston D: Small advances. Nature 450(7173), 1141 (2007).
12. Igarashi E: Factors affecting toxicity and efficacy of polymeric nanomedicines. Toxicol. Appl. Pharmacol. 229(1), 121-134 (2008).
13. 2 particles in cultured human lymphoblastoid cells. Mutat. Res. 628(2), 99-106 (2007).
14. Dunford R, Salinaro A, Cai L et al.: Chemical oxidation and DNA damage catalysed by inorganic sunscreen ingredients. FEBS Lett. 418(1-2), 87-90 (1997).
15. Stearns RC, Paulauskis JD, Godleski JJ: Endocytosis of ultrafine particles by A549 cells. Am. J. Respir. Cell. Mol. Biol. 24(2), 108-115 (2001).
16. Dick CA, Brown DM, Donaldson K, Stone V: The role of free radicals in the toxic and inflammatory effects of four different ultrafine particle types. Inhal. Toxicol. 15(1), 39-52 (2003).
17. Monteiller C, Tran L, Macnee W et al.: The pro-inflammatory effects of low-toxicity low-solubility particles, nanoparticles and fine particles, on epithelial cells in vitro: the role of surface area. Occup. Environ. Med. 64(9), 609-615 (2007).
18. Rehn B, Seiler F, Rehn S, Bruch J, Maier M: Investigations on the inflammatory and genotoxic lung effects of two types of titanium dioxide: untreated and surface treated. Toxicol. Appl. Pharmacol. 189(2), 84-95 (2003).
19. Renwick Lc, Brown D, Clouter A, Donaldson K: Increased inflammation and altered macrophage chemotactic responses caused by two ultrafine particle types. Occup. Environ. Med. 61(5), 442-447 (2004).
20. 2 particles: differential responses related to surface properties. Toxicology 230(1), 90-104 (2007).
21. Garabrant DH, Fine LJ, Oliver C, Bernstein L, Peters JM: Abnormalities of pulmonary function and pleural disease among titanium metal production workers. Scand. J. Work Environ. Health 13(1), 47-51 (1987).
22. Gopalan RC, Osman IF, Amani A, De Matas M, Anderson D: The effect of zinc oxide and titanium dioxide nanoparticles in the comet assay with UVA photoactivation of human sperm and lymphocytes. Nanotoxicology 3(1), 33-39 (2009).
23. Brayner R, Ferrari-Iliou R, Brivois N, Djediat S, Benedetti MF, Fievet F: Toxicological impact studies based on Escherichia Coli bacteria in ultrafine ZnO nanoparticles colloidal medium. Nano. Lett. 6(4), 866-870 (2006).
24. 2 to bacteria Vibrio fischeri and crustaceans Daphnia magna and Thamnocephalus platyurus. Chemosphere 71(7), 1308-1316 (2008).
25. Dufour EK, Kumaravel T, Nohynek GJ, Kirkland D, Toutain H: Clastogenicity, photo-clastogenicity or pseudo-photoclastogenicity: genotoxic effects of zinc oxide in the dark, in pre-irradiated or simultaneously irradiated chinese hamster ovary cells. Mutat. Res. 607(2), 215-224 (2006).
26. Sharma V, Shukla RK, Saxena N, Parmar D, Das M, Dhawan A: DNA damaging potential of zinc oxide nanoparticles in human epidermal cells. Toxicol. Lett. 185(3), 211-218 (2009).
27. Kang SJ, Kim BM, Lee YJ, Chung HW: Titanium dioxide nanoparticles trigger p53-mediated damage response in peripheral blood lymphocytes. Environ. Mol. Mutagen 49(5), 399-405 (2008).
28. Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ: In vitro toxicity of nanoparticles in Brl 3a rat liver cells. Toxicol. In vitro 19(7), 975-983 (2005).
29. Rahman Q, Lohani M, Dopp E et al.: Evidence that ultrafine titanium dioxide induces micronuclei and apoptosis in Syrian hamster embryo fibroblasts. Environ. Health Perspect. 110(8), 797-800 (2002).
30. Dhawan A, Taurozzi JS, Pandey AK et al.: Stable colloidal dispersions of c60 fullerenes in water: evidence for genotoxicity. Environ. Sci. Technol. 40(23), 7394-7401 (2006).
31. Lewinski N, Colvin V, Drezek R: Cytotoxicity of nanoparticles. Small 4(1), 26-49 (2008).
32. 2: role of the specific surface area and of surface methylation of the particles. Toxicol. Appl. Pharmacol. 222(2), 141-151 (2007).
33. 2 particulate in cultured human lymphoblastoid cells. Environ. Mol. Mutagen 48(2), 151-157 (2007).
34. Shrivastava S, Bera T, Roy A, Singh G, Ramachandrarao P, Dash D: Characterization of enhanced antibacterial effects of novel silver nanoparticles. Nanotechnology 18(22), 225103 (2007).
35. Wang WQ, Sun JP, Zhang ZY: An overview of the protein tyrosine phosphatase superfamily. Curr. Top. Med. Chem. 3(7), 739-748 (2003).
36. Hubbard SR, Mohammadi M, Schlessinger J: Autoregulatory mechanisms in proteintyrosine kinases. J. Biol. Chem. 273(20), 11987-11990 (1998).
37. Kusumoto H, Maehara Y, Anai H, Kusumoto T, Sugimachi K: Potentiation of adriamycin cytotoxicity by dipyridamole against HeLa cells in vitro and sarcoma 180 cells in vivo. Cancer Res. 48(5), 1208-1212 (1988).
38. Cole SP, Sparks KE, Fraser K et al.: Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res. 54(22), 5902-5910 (1994).
39. Lebret V, Raehm L, Durand J-O et al.: Surface functionalization of two-photon dye-doped mesoporous silica nanoparticles with folic acid: cytotoxicity studies with HeLa and MCF-7 cancer cells. J. Sol-Gel Sci. Technol. 48(1-2), 32-39 (2008).
40. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65(1-2), 55-63 (1983).
41. Khan JA, Pillai B, Das TK, Singh Y, Maiti S: Molecular effects of uptake of gold nanoparticles in HeLa cells. Chembiochem. 8(11), 1237-1240 (2007).
42. Uboldi C, Bonacchi D, Lorenzi G et al.: Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines a549 and NCIH441. Part Fibre Toxicol. 6, 18 (2009).
43. Borenfreund E, Puerner JA: Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol. Lett. 24(2-3), 119-124 (1985).
44. Henderson L, Wolfreys A, Fedyk J, Bourner C, Windebank S: The ability of the comet assay to discriminate between genotoxins and cytotoxins. Mutagenesis 13(1), 89-94 (1998).
45. Tice RR, Agurell E, Anderson D et al.: Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ. Mol. Mutagen 35(3), 206-221 (2000).
46. Fenech M: The cytokinesis-block micronucleus technique: a detailed description of the method and its application to genotoxicity studies in human populations. Mutat. Res. 285(1), 35-44 (1993).
47. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275 (1951).
48. Stone V, Johnston H, Clift MJ: Air pollution, ultrafine and nanoparticle toxicology: cellular and molecular interactions. IEEE Trans. Nanobiosci. 6(4), 331-340 (2007).
49. Xia T, Kovochich M, Brant J et al.: Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano. Lett. 6(8), 1794-1807 (2006).
50. Donaldson K, Stone V: Current hypotheses on the mechanisms of toxicity of ultrafine particles. Ann. Ist Super Sanita 39(3), 405-410 (2003).
51. Friedberg EC, Meira LB: Database of mouse strains carrying targeted mutations in genes affecting biological responses to DNA damage (version 6). DNA Repair (Amst.) 3(12), 1617-1638 (2004).
52. Rusyn I, Asakura S, Pachkowski B et al.: Expression of base excision DNA repair genes is a sensitive biomarker for in vivo detection of chemical-induced chronic oxidative stress: identification of the molecular source of radicals responsible for DNA damage by peroxisome proliferators. Cancer Res. 64(3), 1050-1057 (2004).
53. Mroz RM, Schins RP, Li H et al.: Nanoparticle-driven DNA damage mimics irradiation-related carcinogenesis pathways. Eur. Respir. J. 31(2), 241-251 (2008).
54. Schins RP, Knaapen AM: Genotoxicity of poorly soluble particles. Inhal. Toxicol. 19(Suppl. 1), 189-198 (2007).
55. Glenney JR Jr: Tyrosine phosphorylation of a 22-kDa protein is correlated with transformation by rous sarcoma virus. J. Biol. Chem. 264(34), 20163-20166 (1989).
56. Blume-Jensen P, Hunter T: Oncogenic kinase signalling. Nature 411(6835), 355-365 (2001).
57. Hahn WC, Weinberg RA: Modelling the molecular circuitry of cancer. Nat. Rev. Cancer 2(5), 331-341 (2002).
58. Jiang H, Luo S, Li H: CDk5 activatorbinding protein c53 regulates apoptosis induced by genotoxic stress via modulating the G2/m DNA damage checkpoint. J. Biol. Chem. 280(21), 20651-20659 (2005).
59. Wan R, Mo Y, Zhang X, Chien S, Tollerud DJ, Zhang Q: Matrix metalloproteinase-2 and -9 are induced differently by metal nanoparticles in human monocytes: the role of oxidative stress and protein tyrosine kinase activation. Toxicol. Appl. Pharmacol. 233(2), 276-285 (2008).
60. Bae D, Camilli TC, Chun G et al.: Bypass of hexavalent chromium-induced growth arrest by a protein tyrosine phosphatase inhibitor: enhanced survival and mutagenesis. Mutat. Res. 660(1-2), 40-46 (2009).
61. Furlong F, Finlay D, Martin F: PTPase inhibition restores ERK1/2 phosphorylation and protects mammary epithelial cells from apoptosis. Biochem. Biophys. Res. Commun. 336(4), 1292-1299 (2005).
62. Lovern SB, Klaper R: Daphnia magna mortality when exposed to titanium dioxide and fullerene (c60) nanoparticles. Environ. Toxicol. Chem. 25(4), 1132-1137 (2006).
63. 2 and ZnO water suspensions. Water Sci. Technol. 54(11-12), 327-334 (2006).
64. Brunner TJ, Wick P, Manser P et al.: In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. Environ. Sci. Technol. 40(14), 4374-4381 (2006).
65. 2 to a freshwater microalga (Pseudokirchneriella subcapitata): the importance of particle solubility. Environ. Sci. Technol. 41(24), 8484-8490 (2007).
66. Xia T, Kovochich M, Liong M et al.: Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano 2(10), 2121-2134 (2008).